Calmer Co International (ASX:CCO) is expecting good things in FY26
Calmer Co International (ASX:CCO) closed out FY25 with $8m in revenue, which was 86% ahead of 12 months ago. As…
Scope One And Two Emissions: What Are They And Why They’re Important for Investors to Watch
Investors have long known that emissions have been a problem and increasingly scruitanised, but they may not know what so-called…
Trump’s Proposed 50% Copper Tariff: Impact on BHP, Copper Prices, and ASX Miners
Donald Trump’s proposed 50% tariff on copper imports is certainly making headlines, and while it may shake things up in…
Here are 5 ESG metrics to look at to give you an edge in investing!
Here are 5 ESG metrics to look at! 1. Employee Turnover Common criticisms of ESG metrics is that some have…
BPM Minerals (ASX:BPM): Picking up unfinished business from AngloGold Ashanti and IGO
Last week was a big week for BPM Minerals (ASX:BPM). It sold its Claw Gold Project to Capricorn (ASX:CMM) for…
What is a contrarian investor, who are some of the most famous ones and can I make money if I adopt this strategy?
What is a contrarian investor? Are they nobodies on the fringe of the market? Or are they the prophets you…
Here Are 4 Dogs of the ASX that will Bounce Back With a Vengeance in FY26, and 4 That Won’t
Have you ever heard the term Dogs of the ASX? It can either allude to the worst stocks in the…
Johns Lyng Group (ASX:JLG): Taking the easy way out with a $1.1bn buyout
The tenure of Johns Lyng Group (ASX:JLG) is ending with Pacific Equity Partners buying it out for $1.1bn after several…
Here are 9 of the most successful hedge fund managers of all time
To say the most successful hedge fund managers have made a lot of money from the stock market is an…
SDI (ASX:SDI): Will slow and steady win the race?
If you’re looking for a stock that’ll make you a fortune, SDI (ASX:SDI) might not be the best one for…
Lifestyle Communities (ASX: LIC) Shares Plunged 38%: What the Exit Fees Tribunal Ruling Means for Investors
Lifestyle Communities (ASX: LIC) shares experienced a dramatic drop of around 38% after a Victorian Civil and Administrative Tribunal (VCAT)…
Orphan Drug Designation: What is it and why is it a big deal for biotech stocks?
While most small cap health stocks dream of commercialisation, healthcare companies at an early stage get excited about achieving Orphan…
ASX Real Estate Stocks Are Finally Out of the Doldrums: But These 6 Are Standing Above The Rest
FY25 was finally the year ASX Real Estate Stocks broke out of their post-COVID slump, netting an average return of…
Top 5 ASX Penny Stocks That Outperformed the Market in 2025
Penny stocks have long been associated with high-risk, high-reward investing. For investors with a high tolerance for risk, these stocks…